HANXBIO-B (03378) announced its interim results, reporting a loss attributable to shareholders of 36.883 million yuan, an increase of 1.22% year-on-year.

HANXBIO-B (03378) announced its interim results for the period ending June 30, 2026, reporting other income and gains of 27.614 million yuan (RMB, the same below), an increase of 421.02% year-on-year; loss attributable to owners of the parent company was 36.883 million yuan, a year-on-year increase of 1.22%; basic and diluted loss per share was 0.27 cents. The announcement stated that the increase in other income and gains was mainly due to the increased fair value gains from the variable consideration generated by the sale of an associated company.